{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:07:08Z","timestamp":1786118828228,"version":"build-2736575974"},"reference-count":13,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,7]]},"DOI":"10.1097\/01.pap.0000249926.89087.d8","type":"journal-article","created":{"date-parts":[[2007,7,20]],"date-time":"2007-07-20T04:11:07Z","timestamp":1184904667000},"page":"414-416","source":"Crossref","is-referenced-by-count":17,"title":["Use of Hydromorphone (Dilaudid) and Morphine for Patients With Hepatic and Renal Impairment"],"prefix":"10.1097","volume":"14","author":[{"given":"Mohammad","family":"Razaq","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madelyn","family":"Balicas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nagender","family":"Mankan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-18-20210202","first-page":"13","article-title":"Analgesic therapy in patients with chronic kidney disease. Clinical review article.","volume":"41","author":"Rifkin","year":"2005","journal-title":"Hosp Phys"},{"key":"R2-18-20210202","first-page":"81","article-title":"Pharmacokinetics of oral immediate-release hydromorphone (Dilaudid IR) in subjects with renal impairment.","volume":"44","author":"Durnin","year":"2001","journal-title":"Proc West Pharmacol Soc"},{"key":"R6-18-20210202","first-page":"344","article-title":"Morphine pharmacokinetics and metabolism in humans. Enterohepatic cycling and relative contribution of metabolites to active opioid concentrations.","volume":"24","author":"Hasselstrom","year":"1993","journal-title":"Clin Pharmacokinet"},{"key":"R7-18-20210202","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0885-3924(02)00531-6","article-title":"Relationships among morphine metabolism, pain, and side effects during long-term treatment: an update.","volume":"25","author":"Andersen","year":"2003","journal-title":"J Pain Symptom Manage"},{"key":"R8-18-20210202","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/S0016-5085(81)80005-4","article-title":"Normal metabolism of morphine in cirrhosis.","volume":"81","author":"Patwardhan","year":"1981","journal-title":"Gastroenterology"},{"key":"R9-18-20210202","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1300\/J088v05n04_02","article-title":"Emerging neuropsychiatric toxicities of opioids.","volume":"5","author":"Pereira","year":"1997","journal-title":"J Pharm Care Pain Sympt Control"},{"key":"R10-18-20210202","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S0749-0690(18)30213-1","article-title":"Opioid analgesic drugs in the elderly.","volume":"12","author":"Forman","year":"1996","journal-title":"Clin Geriatr Med"},{"key":"R11-18-20210202","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1111\/j.1399-6576.1993.tb03809.x","article-title":"Myoclonus spasms during treatment with high doses of intravenous morphine in renal failure.","volume":"37","author":"Sjogren","year":"1993","journal-title":"Acta Anaesthesiology Scand"},{"key":"R14-18-20210202","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/00000542-199407000-00013","article-title":"Plasma and cerebrospinal fluid concentration morphine and morphine glucuronides after oral morphine. The influence of renal failure.","volume":"81","author":"DHonneur","year":"1994","journal-title":"Anesthesiology"},{"key":"R16-18-20210202","first-page":"83","article-title":"Pharmacokinetics of oral immediate-release hydromorphone (Dilaudid IR) in subjects with moderate hepatic impairment.","volume":"44","author":"Durnin","year":"2001","journal-title":"Proc West Pharmacol Soc"},{"key":"R17-18-20210202","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0272-6386(03)00645-0","article-title":"Analgesia in patients with ESRD: a review of available evidence.","volume":"42","author":"Kurella","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"R18-18-20210202","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1191\/026921601669626431","article-title":"Retrospective study of the use of hydromorphone in palliative care patients with normal and abnormal urea and creatinine.","volume":"15","author":"Lee","year":"2001","journal-title":"Palliat Med"},{"key":"R19-18-20210202","first-page":"6","article-title":"The role of palliative care in patients with renal failure.","volume":"5","author":"Rich","year":"2000","journal-title":"Brit J Renal Med"}],"container-title":["American Journal of Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/01.pap.0000249926.89087.d8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T16:49:09Z","timestamp":1786034949000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00045391-200707000-00018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,7]]},"references-count":13,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/01.pap.0000249926.89087.d8","relation":{},"ISSN":["1075-2765"],"issn-type":[{"value":"1075-2765","type":"print"}],"subject":[],"published":{"date-parts":[[2007,7]]}}}